In today’s fast-paced clinical environment, it is helpful to understand how ultrasound integrates new artificial intelligence technologies to best serve both physicians and patients. Specifically, how AI can improve patient satisfaction, increase medical professionals’ workflow efficiency, expand scientific knowledge and explore disease prediction models.

• To review the different types of machine learning (ML) techniques
• To understand how ML algorithms could be incorporated in practice to improve echo lab workflow
• Characterize the challenges and opportunities related to the application of AI in echocardiography in the COVID-19 era
• Understand the potential for AI technology in improving patient satisfaction and clinical outcomes

The content of this SDMD CME Symposium is intended for sonographers, and other healthcare professionals involved in echocardiography.

This program has been submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 09/10/2022 | Expires: 09/10/2023

Jordan B. Strom, MD, MSc, FACC, FASE

• Edwards Life Sciences
• Bracco
• Ultromics and Heart Sciences

Patricia A. Pellikka, MD, FACC, FAHA, FASE

• Ultromics LTD
• American Society of Echo Foundation

Partho Sengupta, MD, DM, FACC, FASE

• Ultromics LTD
• Kencor Health
• RCE Technologies

Jordan B. Strom
MD, MSc, FACC, FASE

Harvard Medical School
Boston, MA

Patricia A. Pellikka
MD, FACC, FAHA, FASE

Mayo Clinic
Rochester, MN

Partho Sengupta
MD, DM, FACC, FASE

WVU Heart & Vascular Institute
Morgantown, WV

Hypersensitivity reactions to the polyethylene glycol component of lipid stabilized UEAs have recently been recognized but are extremely rare. Physicians, sonographers, and nurses involved in the practice of echocardiography require information on related recommended changes to echo laboratory policy involving the use of UEAs. This webinar brings together experts in the field, where they will discuss:

1. The mechanisms of hypersensitivity reactions to ultrasound enhancing agents (UEAs), including new information implicating hypersensitivity to polyethylene glycol
2. Established new contraindications to UEAs
3. New information to laboratory policy for UEAs

1. Summarize the mechanisms of hypersensitivity reactions to ultrasound enhancing agents (UEAs), including new  information implicating hypersensitivity to polyethylene glycol
2. Recognize established and new contraindications to UEAs
3. Translate this new information to laboratory policy for UEAs

The content of this SDMS CME symposium is intended for sonographers and other healthcare professionals involved in echocardiography.

This program has been submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 07/26/2022 | Expires: 07/26/2023

Jonathan R. Lindner MD, FASE, FACC

• Lantheus Medical Imaging
• GE Healthcare

Sharon L. Mulvagh MD, FRCPC, FACC, FAHA, FASE

• No Disclosures

Joan J. Olson B.S, ACS, RDCS, RVT, FASE

• No Disclosures

Anthony Montanaro MD, FACP, FAAAI, FACAI

• Merck Regeneron Teva
• AstraZeneca
• Avillion

Jonathan R. Lindner, MD, FASE, FACC

M. Lowell Edwards
Professor of Cardiology,
Oregon Health and Science
University
Portland, Oregon

Sharon L. Mulvagh, MD, FRCPC, FACC, FAHA, FASE

Professor of Medicine, Cardiologist,
Dalhousie University,
Emeritus Professor of Medicine,
Cardiovascular Diseases, Mayo Clinic
Halifax, Nova Scotia, Canada

Joan J. Olson, B.S, ACS, RDCS, RVT, FASE

Echocardiography & Nuclear
Imaging Manager
Nebraska Medicine
Omaha, Nebraska

Anthony Montanaro, MD, FACP, FAAAI, FACAI

Medical Director of Northwest
Research, Head Division of
Allergy & Immunology, OHSU
Portland, Oregon